Location: Boston, MA
CIK: 0001040508 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 13, 2024
Total Value: $4.612B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| — | CEREVEL THERAPEUTICS HLDNG I | 65,679,781 | $2.785B | 60.4% | $42.40 | — | — | COM | 15678U128 |
| SGRY | SURGERY PARTNERS INC | 49,946,972 | $1.598B | 34.6% | $31.99 | — | — | COM | 86881A100 |
| AVAH | AVEANNA HEALTHCARE HLDGS INC | 81,600,880 | $219M | 4.7% | $2.68 | — | — | COM | 05356F105 |
| ADV | ADVANTAGE SOLUTIONS INC | 2,890,000 | $10.46M | 0.2% | $3.62 | — | — | COM CL A | 00791N102 |